Tag: Irish pharmaceutical industry
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
John Whelan discusses the implications of Trump's tariff plan on generic drugs and how it raises concerns for Ireland's pharmaceutical landscape.
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
John Whelan discusses the implications of Trump's tariffs on generic drugs and their potential impact on Ireland's pharmaceutical industry.
John Whelan: Trump’s Generic Drug Tariff Plan Raises Irish Concerns
The recent announcement of a generic drug tariff plan by former President Trump has sparked significant concerns in Ireland, highlighting potential impacts on the pharmaceutical sector and public health.
